AusperBio Secures $120 Million Series C Funding for Hepatitis B Therapy Development
Biotechnology firm AusperBio has successfully closed a $120 million Series C financing round to advance its experimental hepatitis B treatment, AHB-137. The capital will support clinical development and potential commercialization efforts for the next-generation antiviral drug.
The Story
Analyzing sources…
Source Diversity
Source Diversity
Moderate (27/100)Sources
AusperBio Completes $120 Million Series C Financing to Advance AHB-137 Toward Potential Commercialization and Expand Next-Generation HBV Therapies - Morningstar
AusperBio Completes $120 Million Series C Financing to Advance AHB-137 Toward Potential Commercialization and Expand Next-Generation HBV Therapies Morningstar
Read full article →A social media app that feels like the old Instagram days raised $21 million
Retro is a social media app for sharing content with friends and family. Screenshot/Retro/BI Retro, designed by ex-Instagram employees, is a social app for sharing content with close friends. The startup behind it has raised $21 million, recent financial filings reveal. It's one of many new social media apps taking on Big Tech platforms. There's a social media app I like using more than Instagram or TikTok — and it's attracted serious investor interest. The app, called Retro, is an Instagra...
Read full article →